Share Facebook Twitter LinkedIn Pinterest Email Notable healthcare headlines for the week: Abbott, Medtronic, Merck and J&J in focus
DPC initiates FY 2026 guidance of $1.0B-$1.04B revenue and $182M-$187M adjusted EBITDA as it advances Alabama superalloy site (NYSE:DPC)August 11, 2026